Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
107.46
64.38
57.42
51.35
55.31
71.86
73.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
107.46
64.38
57.42
51.35
55.31
71.86
73.41
Raw Material Cost
5.51
6.01
6.05
6.59
7.29
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.46
2.55
2.35
6.37
8.55
44.59
31.86
Selling and Distribution Expenses
79.28
64.76
65.94
63.08
95.51
105.32
102.86
Other Expenses
3.35
3.35
3.64
5.44
18.16
21.31
18.41
Total Expenditure (Excl Depreciation)
120.71
106.82
110.72
130.47
292.95
362.97
318.81
Operating Profit (PBDIT) excl Other Income
-13.200000000000001
-42.400000000000006
-53.3
-79.1
-237.60000000000002
-291.1
-245.39999999999998
Other Income
144.95
4.88
9.12
8.54
1.11
71.27
42.10
Operating Profit (PBDIT)
137.22
-31.54
-38.12
-63.98
-229.25
-219.84
-203.29
Interest
2.46
2.55
2.35
6.37
8.55
44.59
31.86
Exceptional Items
0.00
-4.51
-2.74
-15.87
-20.14
-15.46
0.00
Gross Profit (PBDT)
101.95
58.37
51.37
44.76
48.02
0.00
0.00
Depreciation
5.51
6.01
6.05
6.59
7.29
6.64
6.52
Profit Before Tax
129.25
-44.61
-49.27
-92.81
-265.22
-286.54
-241.68
Tax
23.35
11.80
5.92
0.01
-0.15
-8.52
-5.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.89
-56.42
-55.19
-92.82
-265.07
-278.02
-236.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.89
-56.42
-55.19
-92.82
-265.07
-278.02
-236.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
105.89
-56.42
-55.19
-92.82
-265.07
-278.02
-236.46
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
296.72
175.54
213.00
441.80
-338.57
-303.75
-223.84
Earnings per share (EPS)
2.06
-1.16
-1.0
-3.65
-2.87
-4.46
-4.25
Diluted Earnings per share
2.06
-1.16
-1.0
-3.65
-2.87
-4.46
-4.25
Operating Profit Margin (Excl OI)
-12.33%
-65.91%
-92.8%
-154.09%
-429.65%
-414.37%
-343.14%
Gross Profit Margin
125.4%
-59.96%
-75.26%
-167.93%
-466.34%
-389.51%
-320.31%
PAT Margin
98.54%
-87.63%
-96.11%
-180.78%
-479.24%
-386.9%
-322.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 66.93% vs 12.20% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 287.77% vs -2.17% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 78.85% vs 22.88% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 4.17% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Theravance Biopharma, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
107.46
7.83
99.63
1,272.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
107.46
7.83
99.63
1,272.41%
Raw Material Cost
5.51
7.28
-1.77
-24.31%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.46
0.00
2.46
Selling and Distribution Expenses
79.28
21.77
57.51
264.17%
Other Expenses
3.35
5.26
-1.91
-36.31%
Total Expenditure (Excl Depreciation)
120.71
81.70
39.01
47.75%
Operating Profit (PBDIT) excl Other Income
-13.25
-73.88
60.63
82.07%
Other Income
144.95
11.45
133.50
1,165.94%
Operating Profit (PBDIT)
137.22
-61.97
199.19
321.43%
Interest
2.46
0.00
2.46
Exceptional Items
0.00
-2.50
2.50
100.00%
Gross Profit (PBDT)
101.95
0.54
101.41
18,779.63%
Depreciation
5.51
0.45
5.06
1,124.44%
Profit Before Tax
129.25
-64.92
194.17
299.09%
Tax
23.35
0.00
23.35
Provisions and contingencies
0
0
0.00
Profit After Tax
105.89
-64.92
170.81
263.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
105.89
-64.92
170.81
263.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
105.89
-64.92
170.81
263.11%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
296.72
103.08
193.64
187.85%
Earnings per share (EPS)
2.06
-0.53
2.59
488.68%
Diluted Earnings per share
2.06
-0.53
2.59
488.68%
Operating Profit Margin (Excl OI)
-12.33%
-943.97%
0.00
931.64%
Gross Profit Margin
125.40%
-823.78%
0.00
949.18%
PAT Margin
98.54%
-829.58%
0.00
928.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 10.75 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 66.93% vs 12.20% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 10.59 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 287.77% vs -2.17% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.77 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 78.85% vs 22.88% in Dec 2024
Annual - Interest
Interest 0.25 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 4.17% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -12.33%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
